Source: PR Newswire

Press Release: Goodpath : Goodpath Expands Direct-to-Employer and Self-Pay Access to Wegovy Through Novo Nordisk Collaboration

New DTE and self-pay employer pathways support flexible program design and transparent GLP-1 costs, with clinically-led prescribing and care plans Goodpath's whole-person weight care approach treats the comorbidities that drive total cost of care Goodpath supports both oral and injectable...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Bill Gianoukos's photo - Co-Founder & CEO of Goodpath

Co-Founder & CEO

Bill Gianoukos

CEO Approval Rating

80/100

Read more